Skip to main content

Table 1 Basic clinical characteristics of Control, PCOM, and PCOS groups

From: The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study

 

Control ( n  = 9316)

PCOM ( n  = 2879)

PCOS ( n  = 3775)

P value

Age (y)

29.19 ± 2.982,3

28.06 ± 3.0791

28.05 ± 3.0731

 < 0.001*

BMI (kg/m2)

22.36 ± 3.062,3

22.85 ± 3.311,3

24.34 ± 3.581,2

 < 0.001*

T (ng/ml)

0.24 ± 0.102,3

0.28 ± 0.101,3

1.18 ± 6.191,2

 < 0.001*

AMH (ng/ml)

2.92 ± 1.552,3

5.27 ± 2.551,3

7.55 ± 4.001,2

 < 0.001*

LH/FSH

0.77 ± 0.402,3

0.98 ± 0.551,3

1.68 ± 1.121,2

 < 0.001*

  1. Data were presented as the mean ± SD. PCOS Polycystic ovary syndrome, PCOM Polycystic ovary morphology, BMI Body mass index, T Testosterone, AMH Anti-Müllerian hormone, FSH Follicle stimulating hormone, LH Luteinizing hormone
  2. *P: significant difference among the groups. 1P: significant difference from the control group; 2P: significant difference from the PCOM group; 3P: significant difference from the PCOS group